Atlas Trials

An Open-Label Trial of Tocilizumab in Schizophrenia

Clinical trial NCT01696929 · COMPLETED

Trial details

NCT number
NCT01696929
Sponsor
Brian Miller
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2012-09-01
Primary completion
2014-12-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.